JBIO (Jade Biosciences) FCF Margin %: 0.00% (As of Mar. 2026)


JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $22.00
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences FCF Margin %?

Jade Biosciences JBIO +0.87% 12 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Jade Biosciences ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Jade Biosciences's Free Cash Flow for the three months ended in Mar. 2026 was $-24.08 Mil. Jade Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Jade Biosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Jade Biosciences's current FCF Yield % is -7.47%.

The historical rank and industry rank for Jade Biosciences's FCF Margin % or its related term are showing as below:


JBIO's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Jade Biosciences FCF Margin % Related Terms

Jade Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences FCF Margin % Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 0.00

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JBIO vs CRVS, ABSI, SVRA: FCF Margin % Comparison

For the Biotechnology subindustry, Jade Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jade Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jade Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Jade Biosciences's FCF Margin % falls into.


JBIO
12GF Score
Jade Biosciences Inc JBIO
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Jade Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-94.885/0
= %

Jade Biosciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-24.081/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Jade Biosciences (JBIO) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jade Biosciences and its competitors. According to the industry distribution chart, Jade Biosciences ranks #999999 out of 959 companies in the Biotechnology industry.
Is Jade Biosciences' FCF Margin % too high?
Jade Biosciences' current FCF Margin % is 0.00%. Based on the distribution chart, Jade Biosciences ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' FCF Margin % compare to CRVS and ABSI?
According to the Biotechnology industry distribution chart, Jade Biosciences ranks #999999 out of 959 companies for FCF Margin %. This places Jade Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price